ANRO   $14.27  1.75% Market Closed After Close 5.99 -58.02%

Alto Neuroscience Inc
Total Cash 193.12M
totalCashPerShare 7.164
EBITDA -53.83M
Total Debt 10.06M
quickRatio 19.62
currentRatio 19.853
Total Revenue
debtToEquity 5.595
Revenue/Share
ROA
ROE
grossProfits
freeCashflow
operatingCashflow -41.97M
earningsGrowth
revenueGrowth
grossMargins 0.0
ebitdaMargins 0.0
operatingMargins 0.0
profitMargins 0.0
enterpriseValue 202.18M
forwardPE -5.341912
floatShares 19.39M
sharesOutstanding 26.96M
sharesShort 4.12M
sharesShortPriorMonth 3.06M
dateShortInterest
sharesPercentSharesOut 0.15%
heldPercentInsiders 0.08%
heldPercentInstitutions 0.75%
Short Ratio help_outline 9.67%
shortPercentOfFloat 0.19%
impliedSharesOutstanding
bookValue 6.671
Price To Book help_outline 2.18
earningsQuarterlyGrowth
netIncomeToCommon -49.80M
trailingEps -1.85%
forwardEps -2.72%
enterpriseToEbitda -3.76
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.64 3Q 2024
institutionsCount 83
lastUpdated Oct. 22, 2024, 11:33 p.m.